Spruce Capital, Xeraya pulls in $150m for biogreentech Fund II

Venture capital investor Spruce Capital Partners and lifesciences-focused Xeraya Capital have held a $150m first close of their Malaysian Life Sciences Capital Fund II, which will be used to invest in biogreentech companies.